SABCS 2014: N9831 Trial Commentary by Dr. Edith Perez

Stromal tumor-infiltrating lymphocytes(S-TILs): In the alliance N9831 trial S-TILs are associated with chemotherapy benefit but not associated with trastuzumab benefit